NAMS - NewAmsterdam Pharma Company NV - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

485.6M

Cash

438.5M

Avg Qtr Burn

N/A

Short % of Float

0.50%

Insider Ownership

9.62%

Institutional Own.

66.99%

Qtr Updated

12/31/22

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Obicetrapib Details Heterozygous familial hypercholesterolemia	Phase 3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Obicetrapib + ezetimibe Details Dyslipidemia, Hypercholesterolemia	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Obicetrapib Details Heterozygous familial hypercholesterolemia	Phase 2a Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.